BAC
Bank of America Corporation
BAC has lower modeled downside risk, despite its lower overall score.
BCS
Barclays PLC
BCS has the edge over BAC overall on the model score.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
BCS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BCS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BCS.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over BCS in the historical PE scenario, which offers more potential upside but is not a forecast.
BCS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 5.1x | $13.63 | -40% |
| Fair | 8.4x | $22.57 | -1.2% |
| Current | 8.5x | $22.84 | — |
| Expensive | 11x | $29.76 | +30% |
Historical ranges are pointers, not guarantees.
BCS's PE is 8.5x, but its earnings don't support one, so it isn't a reliable read right now.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
BCS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for BCS, with profitability improving.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC's earnings per share have climbed steadily: $4.19 over the past year, up 14% from the year before, and higher year over year for eight quarters in a row.
BCS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $2.69 | +26% |
| Q2 2026 | $2.58 | +18% |
| Q1 2026 | $2.31 | +14% |
| Q4 2025 | $2.26 | +22% |
| Q3 2025 | $2.14 | +44% |
| Q2 2025 | $2.19 | +62% |
| Q1 2025 | $2.02 | +45% |
| Q4 2024 | $1.86 | +29% |
BCS has the edge over BAC on earnings, with stronger typical year-over-year growth.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the edge over BCS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
BCS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $9.8B | +9.6% |
| Q2 2026 | $11.2B | +23% |
| Q1 2026 | $10.8B | +8.7% |
| Q4 2025 | $9.1B | -0.3% |
| Q3 2025 | $8.9B | +6.4% |
| Q2 2025 | $9.1B | +8.6% |
| Q1 2025 | $10B | +8.4% |
| Q4 2024 | $9.2B | +26% |
BCS's revenue is growing: $9.8B last quarter, up 9.6% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 31% | +0.3 points |
| Q2 2026 | 39% | +3.7 points |
| Q1 2026 | 35% | 0 points |
| Q4 2025 | 27% | +2 points |
| Q3 2025 | 31% | -3.3 points |
| Q2 2025 | 35% | +4.7 points |
| Q1 2025 | 35% | +2 points |
| Q4 2024 | 25% | +23 points |
BCS has the edge over BAC on profitability, with a higher operating margin.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC has the edge over BCS on cash flow, with more consistent year-over-year improvement.
BCS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $0 | $0 |
| Q2 2026 | $0 | $0 |
| Q1 2026 | $0 | $0 |
| Q4 2025 | $0 | $0 |
| Q3 2025 | $0 | $0 |
| Q2 2025 | $0 | $0 |
| Q1 2025 | $0 | $0 |
| Q4 2024 | $0 | $0 |
BCS's free cash flow was $0 over the past year, against $0 the year before. Free cash flow isn't a meaningful measure for financial services companies like BCS.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over BCS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
BCS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -2.2% | -75.1M shares |
| 1 year | -4.4% | -155M shares |
| 3 years | -13% | -495M shares |
| 5 years | -21% | -909M shares |
| Available history | -22% | -942M shares |
BCS has 3.4B diluted shares, down 4.4% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
BCS hasn't bought back shares in the past year.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
BCS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -23.9x | Net Cash |
| Q2 2026 | -10.7x | Net Cash |
| Q1 2026 | -10.7x | Net Cash |
| Q4 2025 | -1.1x | Net Cash |
| Q3 2025 | -28.6x | Net Cash |
| Q2 2025 | -12.1x | Net Cash |
| Q1 2025 | -15.3x | Net Cash |
| Q4 2024 | -3.0x | Net Cash |
BCS has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
BCS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.0 | Neutral |
| Stochastic | 15.1 | Oversold |
BCS's weekly RSI is 40 (neutral) and its Stochastic is 15 (oversold).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
BCS PE vs Financial Services Sector
| Metric | BCS | Sector median | Relative |
|---|---|---|---|
| PE | 8.5x | 13x | 35% below |
| PE % | 51 | 63 | 12 pts below |
BCS has the edge over BAC on valuation relative to its sector.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
BCS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $22.9 | 0.4% below |
| 20 week MA | $25.5 | 10% below |
| 50 week MA | $24.8 | 7.7% below |
| 100 week MA | $21.2 | 7.8% above |
| 200 week MA | $15.2 | 50% above |
BCS has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has the edge over BCS on returns for 2026, with the stronger performance.
BCS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.45 | $8.11 | -14% |
| 2021 | $8.11 | $10.2 | +26% |
| 2022 | $10.2 | $7.79 | -24% |
| 2023 | $7.79 | $7.88 | +1.2% |
| 2024 | $7.88 | $13.3 | +69% |
| 2025 | $13.3 | $25.7 | +94% |
| 2026 YTD | $25.7 | $22.8 | -11% |
BCS has finished higher in four of the last six years, two of them by more than 50%. It's down 11% so far in 2026.